Pharmacy business plan in Boulogne-Billancourt

Factual data · GO/NO-GO verdict · Financial model calibrated over 96 months

Market context

A pharmacy in Boulogne-Billancourt generates 2M €-6.1M € € revenue, with net margin of 8 %. Typical mix: 75-85 % prescription drugs (regulated margin), 15-25 % OTC/wellness (free margin 35-45 %).

Key indicators

Initial investment
1.2M € 5.1M €
Depending on location and positioning
Year 1 revenue
2M € 6.1M €
Year 1 target, ramp to 1.2-1.4x by year 3
Average ticket
24 € 61 €
8 % target net margin
Payback period
96 months
Typical steady-state payback

Economic profile of the area

Population
121K inhabitants
Île-de-France
Country
France
Tier 1 — major metropolis
Setup cost
+45% vs average
Rent + labor index
Purchasing power
+35% vs average
Local disposable income

Dominant profile: business · residentielle

Competition and positioning

Competitive density: high (dense supply, segmentation required).

Dominant players: regulated public-insurance sector, few private chains.

Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.

3-year financial projections

Indicator Year 1 Year 2 Year 3
Year 1 revenue 2M € → 6.1M € ×1,18 (ramp-up) ×1,32 (steady-state)
Target net margin negative to low 4 % 10 %
Working capital (days of revenue) 45-60 d 35-50 d 30-45 d
Cumulative ROI investment ~50 % Payback at 96 months

These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of Boulogne-Billancourt (cost +45% vs average, income +35% vs average).

Main risks to anticipate

Launch milestones

1
Month 0 — Concept validation, location choice, competitive study
2
Month 1-2 — Funding search (equity, bank loan, public guarantees)
3
Month 2-3 — Legal incorporation, leases, trademark, insurance
4
Month 3-5 — Construction, equipment, hiring, process setup
5
Month 5-6 — Pre-opening, local marketing, soft launch, operational tuning
6
Month 6+ — Official opening, gradual ramp-up, first monitoring cycle

Frequently asked questions

How to value a pharmacy in Boulogne-Billancourt?
Standard method: revenue multiplier (80-110 %, 90 % average in Boulogne-Billancourt). Adjusting criteria: gross margin, margin/revenue ratio, revenue structure (% wellness), large-prescription weight, public-health dispensary, real estate (lease premium, area, windows), staff in place, local competition.
Financing for a pharmacy acquisition?
Typical mix: personal contribution 25-35 % (rest to finance = 600K-2.5M €), main bank loan over 12-15 years (specialized pharmacy banks), supplementary loan from drug wholesalers, mutual guarantee, sometimes shareholder agreement. Bank targets cash flow >5 % of revenue after debt service.
What net margin to expect?
Average net margin 8 % of revenue. Gross margin 26-32 % (prescription 22-26 %, OTC 30-38 %, wellness 35-45 %). Main expenses: payroll 12-16 %, rent 1.5-3.5 %, other fixed 4-7 %, financial charges 3-8 %. Top lever is product mix (wellness).
How to grow pharmacy revenue?
Levers: wellness range expansion (baby, dermo-cosmetics, nutrition, sport), in-pharmacy services (vaccination, tests, screening, paid pharmaceutical interviews), e-commerce and click & collect, partnerships with care homes and local associations, dedicated counseling space.

MarketLens coverage

Generate your full study and business plan in minutes

MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.